Results 301 to 310 of about 282,772 (364)

Mathematical Albumin Function for Neonates Undergoing Therapeutic Hypothermia in Comparison with Control Neonates

The Journal of Clinical Pharmacology, EarlyView.
Abstract Hypoxic‐ischemic encephalopathy (HIE) resulting from perinatal asphyxia presents a substantial risk of mortality and long‐term sequelae in neonates. Therapeutic hypothermia (TH) improves both short‐ and long‐term outcomes in near‐term/term neonates with moderate to severe HIE.
Zoë Vander Elst, Thibault Stultjens, Pieter Annaert, Paul Clarke, Isabek Iglesias‐Platas, Elisabeth Agathos, Gozdem Kaykı, Annouschka Laenen, Nadir Yalçın, Anne Smits, Karel Allegaert   +10 more
wiley   +1 more source

Feasibility study of texture-based machine learning approach for early detection of neonatal jaundice. [PDF]

Sci Rep
Phattraprayoon N, Ungtrakul T, Kummanee P, Tavaen S, Pirunnet T, Fuangrod T.   +5 more
europepmc   +1 more source

Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease

The Journal of Clinical Pharmacology, EarlyView.
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis, Elijah J. Weber, Cara Nelson, Ann R. Qin, Timothy R. Watkins, Ahmed A. Othman   +5 more
wiley   +1 more source

Bilirubin Metabolism Does Not Influence Serum Bile Acid Profiles According to LC-MS: A Human Case-Control Study. [PDF]

Int J Mol Sci
Stelzer TC, Krüger R, Ferrario PG, Mölzer C, Wallner M, Marculescu R, Doberer D, Bulmer AC, Wagner KH.   +8 more
europepmc   +1 more source

Effects of Hepatic or Renal Impairment on Pharmacokinetics of Fruquintinib

The Journal of Clinical Pharmacology, EarlyView.
Abstract Fruquintinib (FRUZAQLATM) is a highly selective tyrosine kinase inhibitor of all three vascular endothelial growth factor receptors (‐1, ‐2, and ‐3). Two Phase 1, open‐label, single‐dose studies investigated the impact of hepatic or renal impairment on the pharmacokinetics and tolerability of fruquintinib.
Martha Gonzalez, Zhao Yang, William Schelman, Thomas C. Marbury, Juan C. Rondon, William Smith, Xiaofei Zhou, Neeraj Gupta, Caly Chien   +8 more
wiley   +1 more source

Rapid Resolution of Anabolic Androgenic Steroid-Induced Refractory Pruritus and Bile Cast Nephropathy With Therapeutic Plasma Exchange. [PDF]

JGH Open
Wong S, Con D, Majumdar A.
europepmc   +1 more source

Drug‐induced liver injury associated with exposure to Hangeshashinto

Journal of General and Family Medicine, EarlyView.
While Kampo medicines are deemed relatively safe and associated with few adverse effects, primary care physicians are well advised to be aware of the risk of drug‐induced liver injury in patients prescribed Kampo medicines containing Scutellariae radix, such as Hangeshashinto, in clinical practice and to closely monitor their clinical course.
Kimitoshi Kubo, Issei Ashida, Noriko Kimura   +2 more
wiley   +1 more source

Transjugular Liver Biopsy for Histological Diagnosis of Refractory Ascites and Evaluation of Portal Hypertension. [PDF]

In Vivo
Ishikawa T, Sato R, Natsui H, Iwasawa T, Ogawa M, Kobayashi Y, Sato T, Yokoyama J, Honma T.   +8 more
europepmc   +1 more source

Association between serum total bilirubin levels and 28-day all-cause mortality after intracerebral hemorrhage. [PDF]

Front Neurol
Qiu D, Li G, Dong Y.
europepmc   +1 more source

Biochemical, coagulation, and platelet count profiles among Schistosoma mansoni infected patients attending at selected Dembiya health institutions, Northwest Ethiopia. [PDF]

BMC Microbiol
Abebe W, Lemma W, Tegegne Y, Sisay A, Misganaw T, Ayana S, Kasew D, Debash MN, Zemariam AB, Emagneneh T, Derso A.   +10 more
europepmc   +1 more source